Free Pre-Event Q&A Panel with VSGD
Why Attend
The animal health ecosystem is going through a digital transformation, as disruptive tools reshape the way we think about the prevention and prediction of disease, and veterinarians are increasingly using a variety of new digital solutions to empower them in the workplace and improve their productivity. The growing ‘millenialization’ of pet ownership has resulted in a demand for digital solutions that directly connect the pet owner with the clinic. With 30% of pet owners not currently visiting clinics, practitioners are being forced to adopt solutions that are designed to improve the pet-owner/vet relationship and tackle the longstanding issue of compliance.
At the Digital Veterinary Summit, we bring together 150+ executives from across the animal health and veterinary industry, to examine the sector’s digital trends and dynamics, and showcase the industry’s most exciting emerging technologies.
This is a companion animal focused event showcasing technology innovation, platforms and services for pet owners and the latest digital solutions for veterinary practice.
Who Will Be There
DIGITAL INNOVATION SHOWCASE
6 digital veterinary technology innovators, handpicked by the prestigious selection committee, introduce themselves and their innovations and achievements on the main stage.
If you’re an emerging company with an exciting and disruptive technology, apply to pitch in the showcase today.
Applications are now CLOSED. We will be revealing our finalists shortly.
2021 Global Advisory Board
Sébastien Huron
Author:
Jean-Luc Michel
After graduating from the University of Pharmacy of Lyon with a Doctorate and from EM Lyon Business School with an MBA, Jean-Luc Michel started his career by creating his own consultancy company. He joined the pharmaceutical industry in 1991 spending 10 years developing a solid expertise in consumer healthcare and nutrition. During this period, he held a variety of senior marketing and sales management positions in France at Monsanto (Searle) and at Johnson&Johnson / Merck & Co where he was an Executive Committee member of the French subsidiary.
In 2001, Jean-Luc joined Merial, a leader in the animal health industry, where he held some key senior roles, such as EMEA Marketing Director of the Companion Animal Global Enterprise; Head of Marketing EMEA; Executive Marketing Director (Pet Business) in the US; VP, Head of Pet Vet Business Unit; and in 2016 joined the Executive Committee of Merial as Head of Global Commercial Development.
After the acquisition of Merial by Boehringer Ingelheim, Jean-Luc was appointed Head of Global Companion Animal Strategic Business Unit and became a member of the Executive Committee of the Boehringer Ingelheim Animal Health Business Unit.
Jean-Luc Michel
After graduating from the University of Pharmacy of Lyon with a Doctorate and from EM Lyon Business School with an MBA, Jean-Luc Michel started his career by creating his own consultancy company. He joined the pharmaceutical industry in 1991 spending 10 years developing a solid expertise in consumer healthcare and nutrition. During this period, he held a variety of senior marketing and sales management positions in France at Monsanto (Searle) and at Johnson&Johnson / Merck & Co where he was an Executive Committee member of the French subsidiary.
In 2001, Jean-Luc joined Merial, a leader in the animal health industry, where he held some key senior roles, such as EMEA Marketing Director of the Companion Animal Global Enterprise; Head of Marketing EMEA; Executive Marketing Director (Pet Business) in the US; VP, Head of Pet Vet Business Unit; and in 2016 joined the Executive Committee of Merial as Head of Global Commercial Development.
After the acquisition of Merial by Boehringer Ingelheim, Jean-Luc was appointed Head of Global Companion Animal Strategic Business Unit and became a member of the Executive Committee of the Boehringer Ingelheim Animal Health Business Unit.
Marc Prikazsky
Tom Zerzan
Alan Mackay
Dr. Rhodes has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.
Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine. She has an extensive background in physiology, veterinary medicine, and molecular biology. As a senior research fellow at Merck Research Laboratories for 10 years, she led pre-clinical biology evaluation of several marketed human drugs. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. She worked for Merial Ltd. as director of development projects, leading project teams developing novel compounds for a variety of indications and headed new technology assessment, leading the evaluation of licensing opportunities. In April 2001, she formed AlcheraBio, a consulting, marketing, communications and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies, with clients in the US, European Union, Canada and Australia. AlcheraBio was acquired in 2008 by Argenta, and in 2011, Dr. Rhodes accepted a position as CEO of Aratana Therapeutics, a company developing innovative new medicines for dogs and cats, and subsequently, when the company became public (PETX) served as its Chief Scientific Officer. During her tenure, development was completed on three new pet therapeutics: two new molecules with novel mechanisms of actions were approved by the FDA, and a third drug had FDA registration completed and was approved in August, 2016. She is currently retired and an independent consultant. She is a member of the Board of Directors of ImmuCell (NASDAQ: ICCC) and the Alliance for Contraception in Dogs and Cats, serves on the Scientific Advisory Board of the Found Animals Foundation. She is an adjunct faculty member in the Graduate Animal Science program at Rutgers University.
Linda Rhodes
Dr. Rhodes has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine.
Dr. Rhodes was educated at the University of Pennsylvania School of Veterinary Medicine (VMD) and Cornell University (PhD). She has 28 years of accomplishments in human and animal drug discovery, development, biomedical research, and clinical veterinary medicine. She has an extensive background in physiology, veterinary medicine, and molecular biology. As a senior research fellow at Merck Research Laboratories for 10 years, she led pre-clinical biology evaluation of several marketed human drugs. Dr. Rhodes practiced clinical veterinary medicine for five years, with experience in both companion and farm animal practice. She worked for Merial Ltd. as director of development projects, leading project teams developing novel compounds for a variety of indications and headed new technology assessment, leading the evaluation of licensing opportunities. In April 2001, she formed AlcheraBio, a consulting, marketing, communications and contract research firm specializing in developing new drugs for animals, working with biotechnology and animal health companies, with clients in the US, European Union, Canada and Australia. AlcheraBio was acquired in 2008 by Argenta, and in 2011, Dr. Rhodes accepted a position as CEO of Aratana Therapeutics, a company developing innovative new medicines for dogs and cats, and subsequently, when the company became public (PETX) served as its Chief Scientific Officer. During her tenure, development was completed on three new pet therapeutics: two new molecules with novel mechanisms of actions were approved by the FDA, and a third drug had FDA registration completed and was approved in August, 2016. She is currently retired and an independent consultant. She is a member of the Board of Directors of ImmuCell (NASDAQ: ICCC) and the Alliance for Contraception in Dogs and Cats, serves on the Scientific Advisory Board of the Found Animals Foundation. She is an adjunct faculty member in the Graduate Animal Science program at Rutgers University.
Ms. Turner has been Corporate Vice President of IDEXX since May 2014 and leads the Company’s Europe, Middle East and Asia (EMEA) Companion Animal Commercial Operations. Prior to joining the Company, from 1987 to May 2014, Ms. Turner held various leadership positions at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products and diagnostics. Most recently, Ms. Turner was Divisional Vice President of European Commercial Operations for the Diagnostics Division from 2011 to 2014, and prior to that, Divisional Vice President of Global Strategic Operations for the Diagnostics Division from 2007 to 2011. Ms. Turner holds a bachelor’s degree in marketing and advertising from Syracuse University.
Kathy V. Turner
Ms. Turner has been Corporate Vice President of IDEXX since May 2014 and leads the Company’s Europe, Middle East and Asia (EMEA) Companion Animal Commercial Operations. Prior to joining the Company, from 1987 to May 2014, Ms. Turner held various leadership positions at Abbott Laboratories, Inc., a broad-based healthcare company that manufactures and markets pharmaceuticals, medical products and diagnostics. Most recently, Ms. Turner was Divisional Vice President of European Commercial Operations for the Diagnostics Division from 2011 to 2014, and prior to that, Divisional Vice President of Global Strategic Operations for the Diagnostics Division from 2007 to 2011. Ms. Turner holds a bachelor’s degree in marketing and advertising from Syracuse University.
2021 Speakers
Amanda Boag
Peter Dunkley
Caroline Collins
Caroline is a practicing Vet with over 15years experience and is Clinical Director at Pennard Vets. She believes in finding new and better ways to care for clients and their pets. It is this drive that has lead to constantly innovating and exploring Industry-leading advances to deliver this
Nuala Summerfield
Chris Tufnell
Matthew Salois
Charlie Barton
Clint Latham, J.D
Matt Dobbs
Mark Boddy
Dr. Thom Jenkins
Thom is the Co-Founder and CEO of PetsApp - a client engagement platform for veterinary clinics. He is a vet by training, and has managed veterinary groups both in Asia and the UK.
Adele Williams
Susan Paterson
Dr. Ivan Zakharenkov
Apryle Horbal
Sebastian Gabor
Nick Lloyd
Bob Lester
Audrey Wystrach DVM
Steven Eidelman
Victoria Johnson
Peter Renwick
Oliver Viner
The Agenda
We are delighted to announce the 2021 agenda for the 3rd Annual Digital Veterinary Summit. Simply fill in your details on the right and download the PDF agenda immediately.
Download the 2021 Agenda
2021 Partners
Associate Partner
Zoetis
Website: www.zoetis.com
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2019, the company generated annual revenue of $6.3 billion with approximately 10,600 employees.
For more information, visit www.zoetis.com.
Gold Digital Innovation Partner
vHive
Website: https://vhive.buzz
The University of Surrey is home to the School Veterinary of Medicine including Veterinary Health Innovation Engine (vHive) and Animal Health Innovation Network (AHIN). vHive is a research and innovation centre dedicated to the development and adoption of new digital technologies in animal health. It bridges the technology readiness level gap between the world’s leaders in animal health while leading in the development of transformational digital analytics tools to advance the wellbeing of animals for the benefit of society. vHive is comprised of both academic and commercial experts with the expertise necessary to carry out new, complex endeavours on behalf of partners who require academically verified output and bespoke business development.
AHIN acts as a catalyst, stimulating innovation in animal health through convening academia, research organisations and industry in a connected regional ecosystem of excellence.
Founding partners include The University of Surrey working with Enterprise M3 (EM3 LEP), The Pirbright Institute, Animal and Plant Health Agency, Veterinary Medicines Directorate and Sparsholt College. The network works alongside an ecosystem of industry partners including Zoetis and Mars Petcare and is recognised as High Potential Opportunity by the Department for International Trade for international investment and an asset to UK and global economies.
Silver Event Partner
VetCT
Website: https://www.vet-ct.com/gb/
VetCT was established in 2009 and our mission is to help all vets do their best and feel their best every day. We achieve this through supportive teleconsulting and teleradiology, and by developing and implementing novel educational strategies for veterinary medicine. We work with clients across the veterinary ecosystem globally.
In 2021, we launched the VetCT app, providing instant, flexible, 24/7 access to multidisciplinary specialist support for vets in practice, with the benefits of real-time learning and CPD on clinical cases.
VetCT is built on the principles of high quality, professional work and outstanding customer service, with kindness and empathy at our core.
Plexi
Website: https://www.plexi.vet
Plexi’s patient flow software allows forward-thinking practices to go paper-light, getting rid of whiteboards and paper hospitalisation sheets while streamlining patient workflow, scheduling and internal communication.
The app’s practice-wide and remote availability, built-in drug calculators and reminder systems keep tasks on track and on time, improving patient care and outcomes. At the same time, Plexi’s billing-capture feature significantly boosts practice profitability.
The Plexi team’s mission is one of continual improvement and striving to provide the best possible customer experience and support.
To learn more, contact us at www.plexi.vet
Visionary & Innovation Partner
Association Partner
Association for Veterinary Informatics (AVI)
Website: https://www.avinformatics.org/
Founded by Veterinarians
Founded by a group of about 20 veterinarians, meeting in St. Louis for the 1981 American Veterinary Medical Association (AVMA) convention, the Association for Veterinary Informatics (AVI) operated under the name American Veterinary Computer Society (AVCS) until 1995. In 1998, AVI started the Talbot Informatics Symposium, in memory of Dr. Richard Talbot, a pioneer in veterinary informatics. It currently operates as a non-profit organization recognized by the AVMA.
Our Purpose
The Association for Veterinary Informatics (AVI) is a non-profit international and interdisciplinary organization comprised of individuals involved in biomedical informatics research, design, implementation, education and advocacy within the domain of veterinary medicine. This includes the foundational components of biomedical informatics (knowledge engineering, computer science and information science) as it is applied to clinical research informatics, clinical informatics, bioinformatics, translational medicine and public health.
Our Mission
Our mission is to guide and transform the veterinary profession in understanding, using and extending the practice of informatics.
Media Partners
Pet Business World
Website: www.petbusinessworld.co.uk
Pet Business World is the UK’s leading news magazine and website for the pet and aquatics industry. We distribute 7,711 copies (November 2018) to qualifying pet trade professionals – the biggest circulation in the specialist trade by a considerable margin. The independently-owned magazine was established in 1951 and the website (www.petbusinessworld.co.uk) attracted more than 37 million hits in the 12 months to October 2018 – and rising!
IAHJ - International Animal Health Journal
Website: www.animalhealthmedia.com
IAHJ - International Animal Health Journal is a Peer reviewed by our carefully selected editorial advisory panel, and extensive research network, IAHJ reports on Regulations & Validation, Drug Discovery, Development & Delivery, Clinical Research, Nutrition & Infectious Diseases, Custom & Contract Manufacturing, Primary & Secondary Packaging, Logistics & Supply Chain Management, and Marketing & Authorisation of all Drugs, Devices and Food Products that are used in the treatment of animals.
PetVet Magazine
Website: https://www.petvetmagazine.com/
For veterinarians and staff alike, PetVet Magazine is sure to inspire and educate, as well as highlight the incredible industry of veterinary medicine and the wonderful people that make up the veterinary community. PetVet Magazine is the only vet–centered publication whose focus is less clinical and more personal!
Vet Report
Website: https://www.vetreport.net/
Vet Report is a veterinary news site run by a team of UK qualified vets who understand the challenges within the veterinary sector. We provide a wealth of veterinary news, articles and updates on research, products and events on our website, and Twitter and Facebook feeds to follow stories as they are published, Vet Report offers a forum to share veterinary news and resources.
Veterinary Woman
Website: https://www.veterinarywoman.co.uk/
Aspire – Inspire - Grow
Veterinary Woman is a resource aimed at helping women in the profession to develop the confidence to overcome challenges and aspire to be at the forefront of every area of veterinary influence. With a website hosting articles, podcasts and resources and a thriving and vibrant social media community, Veterinary Woman encourages provides a forum for sharing, celebrating and inspiring women in the profession.
Partner With Us
Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
To discuss your objectives and partnership opportunities please contact [email protected]
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.